伊立替康相關(guān)物質(zhì)A

10-羥基喜樹(shù)堿

Irinotecan USP RC A ; 100 MG

Irinotecan USP Related Compound A ;

10-Hydroxy Camptothecin ;

(S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3’,4’:6,7]indolizi,2-b]quinoline-3,14(4H,12H)-dione ;

CAS # 19685-09-7 ;

C20H16N2O5 ;

MW: 364.35 ;

伊立替康相關(guān)物質(zhì)B

7-乙基-10-羥基喜樹(shù)堿

Irinotecan USP RC B ; 100 MG

Irinotecan USP Related Compound B ;

7-Ethyl-10-Hydroxy Camptothecin ;

(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3’,4’:6,7] indolizi,2-b] quinoline-3,14(4H,12H)-dione ;

CAS # 86639-52-3 ;

C22H20N2O5 ;

MW: 392.4 ;

伊立替康相關(guān)物質(zhì)C

Irinotecan USP RC C ; 10 MG

Irinotecan USP Related Compound C ;

Irinotecan 4-Methyl Analog ;

11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano [3',4':6,7]indolizi,2-b]quinoline-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride ;

C32H37ClN4O6 ;

MW: 609.11 ;

伊立替康相關(guān)物質(zhì)D

Irinotecan USP RC D ; 10 MG

Irinotecan USP Related Compound D ;

Irinotecan R-Isomer  ;

(R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizi,2-b]quinoline hydrochloride, trihydrate ;

C33H45ClN4O9 ;

MW: 677.18 ;

伊立替康相關(guān)物質(zhì)E

Irinotecan USP RC E ; 100 MG

Irinotecan USP Related Compound E ;

7-Ethyl Camptothecin ;

(S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizi,2-b]quinoline-3,14(4H,12H)-dione ;

CAS # 78287-27-1 ;

C22H20N2O4 ;

MW: 376.41 ;